Clovis Oncology to Present at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas

  Clovis Oncology to Present at the Bank of America Merrill Lynch 2013 Health
  Care Conference in Las Vegas

Bank of America Merrill Lynch 2013 Healthcare Conference

Business Wire

BOULDER, Colo. -- May 08, 2013

Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Erle T. Mast, the
Company’s Chief Financial Officer and Executive Vice President, will present
at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday,
May 15, 2013, at 10:40 AM PDT. The conference will be held at the Encore at
the Wynn in Las Vegas.

A live webcast of the presentation can be accessed through the investor
relations section of the Company’s website at www.clovisoncology.com.
Following the live presentation, a replay of the webcast will be available on
the Company’s website for 30 days.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring,
developing and commercializing innovative anti-cancer agents in the U.S.,
Europe and additional international markets. Clovis Oncology targets
development programs at specific subsets of cancer populations, and
simultaneously develops diagnostic tools that direct a compound in development
to the population that is most likely to benefit from its use. Clovis Oncology
is headquartered in Boulder, Colorado, and has additional offices in San
Francisco, California and Cambridge, UK.

Contact:

Clovis Oncology
Anna Sussman, 303-625-5022
asussman@clovisoncology.com
or
Breanna Burkart, 303-625-5023
bburkart@clovisoncology.com
 
Press spacebar to pause and continue. Press esc to stop.